Pre Market 15 July 2025: Nifty Holds Support, Pharma & Telecom Stocks in Focus; Gift Nifty Muted
By CapitalKeeper | Pre Market Opening | Indian Equities | Market Moves That Matter
Nifty closes at 25,082 as bulls defend support. Bharti Airtel, PPL Pharma, and Godrej Properties in focus today. Read full pre-market insights with global cues, technical levels, and intraday strategies.
📊 Market Recap – 14 July 2025
Index | Closing Price |
---|---|
Nifty 50 | 25,082.30 |
Bank Nifty | 56,765.35 |
Sensex | 82,254.46 |
Fin Nifty | 26,802.25 |
Markets witnessed a volatile yet range-bound session on Monday. After early weakness, indices recovered off day’s lows as buying emerged in selected banking, pharma, and midcap counters.
🌐 Global Market & Gift Nifty Cues
- Gift Nifty trades around 25,120, indicating a flat-to-positive open.
- US Markets ended mixed:
- Dow Jones: +0.10%
- Nasdaq: -0.14%
- S&P 500: flat
- Brent Crude: $77.82 – Steady
- Dollar Index (DXY): 104.35 – Stable
- India VIX: 12.72 ↓ – Low volatility zone
Sentiment remains cautious ahead of U.S. retail sales data and Fed commentary midweek.
🔍 Sectoral Outlook – 15 July 2025
Sector | Trend | Remarks |
---|---|---|
Pharma | Bullish | PPL Pharma, Cipla & Sun Pharma showing momentum |
Telecom | Positive | Bharti Airtel accumulating for breakout |
PSU Banks | Sideways | Mixed volumes, wait for confirmation |
Private Banks | Neutral | Consolidation phase, ICICI holding well |
IT | Mild Weakness | Tech majors lack clear direction |
Metals | Stable | Hindalco, Nalco consolidating after gains |
FMCG | Cautious | Weak volume participation |
Realty | Bearish Bias | GodrejProp showing signs of short buildup |
📈 Key Technical Levels
🔸 Nifty (Close: 25,082.30)
- Support: 24,900 / 25,000
- Resistance: 25,185 / 25,300 / 25,395
🔸 Bank Nifty (Close: 56,765.35)
- Support: 56,355 / 56,475
- Resistance: 57,000 / 57,345 / 57,525
📌 A move above 25,185 in Nifty and 57,000 in Bank Nifty can trigger a fresh breakout.
💡 Featured Stock Strategies – 15 July 2025
1️⃣ Godrej Properties – CMP ₹2,242
- Options Strategy:
- PE 2200 @ ₹39
- Wait for Entry: Around ₹25
- Stoploss: ₹18
- Targets: ₹50 / ₹75 / ₹90
📉 Outlook: Weakness visible, ideal for short on rise or options hedge.
2️⃣ Bharti Airtel – CMP ₹1,920
- Buy Zone: ₹1,855 – ₹1,840
- Stoploss: ₹1,795
- Targets: ₹2,000
📈 Outlook: Accumulate on dips; showing strength on long-term charts.
3️⃣ PPL Pharma – CMP ₹207
- View: Expected move to ₹230+ in short term
📈 Bullish breakout setup with good delivery volumes seen.
🧭 Intraday Trading Strategy
- Focus on Buy-on-Dips in Pharma & Telecom.
- Avoid aggressive shorts unless Nifty breaks 24,900 with volume.
- Option strategies can be deployed on volatile counters like GodrejProp.
📌 Key Intraday Levels – At a Glance
Index | Supports | Resistances |
---|---|---|
Nifty | 24,900 / 25,000 | 25,185 / 25,300 |
Bank Nifty | 56,355 / 56,475 | 57,000 / 57,345 |
Fin Nifty | 26,700 / 26,580 | 27,120 / 27,300 |
📉 Derivative Snapshot
- FII Index Longs: 27.95%
- Nifty PCR: 0.76
- Bank Nifty PCR: 0.91
- India VIX: 12.72 – Still low, supports trending moves
🧠 CapitalKeeper View
- Watch for sectoral rotation into pharma, telecom, and selected smallcaps.
- GodrejProp may see selling pressure at highs – options strategy preferable.
- Bharti Airtel setting up for a medium-term breakout – strong risk-reward below ₹1,860.
- Global cues neutral – traders should focus on index levels for confirmation.
📌 For daily trade setups, technical learning, and smart investing tips, stay tuned to CapitalKeeper.in
📌 For more real-time updates, trade setups, and investment insights — follow us on [Telegram] and [WhatsApp Channel] subscribe to our newsletter!

📌 Disclaimer
The content provided on CapitalKeeper.in is for informational and educational purposes only and does not constitute investment, trading, or financial advice. While we strive to present accurate and up-to-date market data and analysis, we make no warranties or representations regarding the completeness, reliability, or accuracy of the information.
Stock market investments are subject to market risks, and readers/investors are advised to conduct their own due diligence or consult a SEBI-registered financial advisor before making any investment decisions. CapitalKeeper and its authors are not liable for any loss or damage, direct or indirect, arising from the use of this information.
All views and opinions expressed are personal and do not reflect the official policy or position of any agency or organization. Past performance is not indicative of future results.By using this website, you agree to the terms of this disclaimer.
Leave a Reply